Day: June 16, 2023
Eezy Plc — STOCK EXCHANGE RELEASE — 16 June 2023 at 11.30
Siina Saksi starts as CEO of Eezy Plc, changes in management team
Siina Saksi, who was appointed in April as Eezy’s CEO, has today started work in the CEO role.
The deputy CEO, director for Professional Services unit, Pasi Papunen will leave the company. HR Director Hanna Lehto does not return to her position from parental leave, but will leave the company.
“I am very pleased that Siina can start her work already now. I wish Siina best of luck and all the success as the new CEO, and I am confident that Eezy is in good professional hands under her leadership. I thank Hanna for her significant contribution in building Eezy into its current form. I warmly thank Pasi for being the acting CEO during this spring and for the significant growth of our Professional services,”...
VEON Appoints Omiyinka Doris Group General Counsel
Written by Customer Service on . Posted in Public Companies.
RWF_5488 – Version 2
Omiyinka Doris VEON’s Group General CounselVEON Appoints Omiyinka Doris Group General Counsel
Amsterdam, 16 June 2023 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that Omiyinka Doris has been appointed Group General Counsel in permanent capacity, effective June 1, 2023. As the Group General Counsel, Omiyinka will continue to report to VEON’s Group Chief Executive Officer, Kaan Terzioglu, and will continue to serve as a member of the Group Executive Committee.
Omiyinka has served as VEON’s Acting Group General Counsel and a member of the Group Executive Committee since October 2022. Previously, she was VEON’s Deputy General Counsel for Securities and Exchange Commission / Disclosure, Finance and Governance.
“I...
Growing Popularity of Complementary and Alternative Medicine Fuels Market Growth
Written by Customer Service on . Posted in Mergers And Acquisitions.
SkyQuest projects that the complementary and alternative medicine market will attain a value of USD 493.67 billion by 2030, with a CAGR of 22.03% over the forecast period (2023-2030). The regulatory landscape is expected to change and there will be active government initiatives in the coming years which will establish strong transnational connections across healing pathways connecting global, national and local movements for alternative medicine. Additionally, government initiatives to support the participation of service providers and patients in the complementary and alternative medicine field by examining standards health throughout the medical systems.
Westford, USA, June 16, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, numerous chronic illnesses, such as cancer and cardiovascular conditions are becoming more common, and...
Quadient: Revolving credit facility renewed in advance with a new maturity in 2028
Written by Customer Service on . Posted in Public Companies.
Revolving credit facility renewed in advance with a new maturity in 2028Quadient’s first Sustainability-linked loanParis, 16 June 2023
Quadient S.A. (Euronext Paris: QDT, eligible for PEA-PME investing), a leader in business solutions for meaningful customer connections through digital and physical channels, announces today the closing of a €300 million syndicated Revolving Credit Facility (RCF).
This Revolving Credit Facility was negotiated with a syndicate of seven international banks including BNP Paribas, Crédit Agricole Corporate and Investment Bank, HSBC Continental Europe, Le Crédit Lyonnais and Société Générale, as mandated lead arrangers and bookrunners. In addition, Société Générale acted as syndication coordinator and Crédit Agricole Corporate and Investment Bank as ESG coordinator and Facility Agent. This €300 million RCF...
Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate
Written by Customer Service on . Posted in Public Companies.
COPENHAGEN, Denmark, June 16, 2023 – Bavarian Nordic A/S (OMX: BAVA) announced today the results of a 12-month follow-up analysis from a subset of subjects enrolled in a Phase 2 clinical trial of ABNCoV2, a VLP-based, non-adjuvanted COVID-19 booster vaccine candidate.
Results from 36 subjects, who had not received a booster dose outside of the trial and had no reports of COVID-19 disease or a positive PCR results for SARS-CoV-2 since vaccination in the study, showed that 12 months post the booster with ABNCoV2, neutralizing antibodies against the Wuhan strain and the previous variants of concern (Beta, Delta and Omicron BA.4/5) remained at levels known to be associated with a high levels of protection (>90%)1. In a separate analysis the sera from a subset of subjects (n=40) enrolled into the Phase 2 trial were tested against a more distant...
INVL Partner Global Infrastructure Fund I raises an additional USD 2.295 million from investors
Written by Customer Service on . Posted in Public Companies.
The INVL Partner Global Infrastructure Fund I, which invests in the infrastructure fund of a long-standing world-class asset manager, attracted an additional USD 2.295 million from investors. Fund is under management by INVL, the leading investment management and life insurance group in the Baltics. The fund’s units were distributed by the INVL Family Office.
After the placement, which ended on 15 June, the INVL Partner Global Infrastructure Fund I had raised a total of USD 44.64 million.
“Investments in infrastructure are more resilient to capital market volatility and act as a hedge against inflation, while at the same time being an attractive asset class for diversifying investment risk. Investment assets are acquired for the long term and generate steady income for investors. Moreover, this is an opportunity to invest in a global...
NB Private Equity: 2H 2023 Dividend of $0.47 per Share
Written by Customer Service on . Posted in Dividend Reports And Estimates.
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS
16 June 2023
Highlights:August 2023 dividend of $0.47 per share, in-line with February 2023 dividend payment
Annualised dividend yield on 31 May 2023 NAV of 3.3%; annualised share price yield is 4.7% based on the closing share price of £15.56 on 15 June 2023
The August 2023 dividend will be NBPE’s 22nd successive dividend payment since initiating dividends in 2013
Including the upcoming dividend payment, NBPE’s total capital returned to shareholders through dividends and buybacks amounts to approximately $316 million since the beginning of 2013While the Company declares dividends in US Dollars, Shareholders will receive Sterling dividends...
ENSU – EX. REPAIR ISSUE TODAY
Written by Customer Service on . Posted in Public Companies.
Issuer name: Ensurge Micropower ASA
Ex. date: 16 June 2023
Type of corporate action: Possible repair issue/subsequent offering
This information is published in accordance with the requirements of the Continuing Obligations.
Cadeler A/S and Eneti Inc. sign business combination agreement to create a leading offshore wind turbine and foundation installation company
Written by Customer Service on . Posted in Public Companies.
MONACO, June 16, 2023 (GLOBE NEWSWIRE) — Cadeler A/S (OSE: CADLR) (“Cadeler”) and Eneti Inc. (NYSE: NETI) (“Eneti”), two offshore wind turbine and foundation installation companies, announce today that they have entered into a business combination agreement to combine (the “Combination“) through a stock-for-stock exchange offer to be made to all stockholders of Eneti based on an exchange ratio of 3.409 Cadeler shares for each Eneti share (the “Exchange Offer”).
Following the completion of the Exchange Offer, Cadeler and Eneti shareholders will own approximately 60% and 40% of the combined company, respectively, on the basis of the share counts for each of Cadeler and Eneti as at 16 June 2023 and assuming all outstanding Eneti shares are exchanged for Cadeler shares in the Exchange Offer.
The combined group will be named...
IMCD Singapore and Vietnam are poised for growth with the acquisition of Brylchem Group
Written by Customer Service on . Posted in Mergers And Acquisitions.
Photo – IMCD Singapore and Vietnam are poised for growth with the acquisition of Brylchem Group
Photographed from left to right:- Fenna van Zanten, M&A Director of IMCD Group- Daan Roebbers, Regional Director Expansion, Strategy, and Digitalisation of IMCD APAC – Tan Seng Kung, Founder & Managing Director of Brylchem Group- Ang Bee Suan, Director of Brylchem Group- Andreas Igerl, President of IMCD APAC- Shellen Chua, General Director of Brylchem GroupROTTERDAM, The Netherlands (June 16, 2023) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, formulator of speciality chemicals and ingredients, and expert solutions provider today announces that IMCD has signed an agreement to acquire 100% of the shares of the speciality distribution company Brylchem Pte Ltd...